logo
'Grown Up' Drug Maker Shanghai Henlius Targets Global Fight To Beat Cancer

'Grown Up' Drug Maker Shanghai Henlius Targets Global Fight To Beat Cancer

Forbes24-06-2025
Shanghai Henlius CEO Jason Zhu. Shanghai Henlius
Drug maker Shanghai Henlius traces its history to 1992, when four ambitious young entrepreneurs formed Fosun Group to seize burgeoning opportunities in the early days of China's economic reforms. Eyeing the rapidly growing country's healthcare needs, it created Fosun Pharmaceuticals in 2004.
Shanghai Henlius was founded by Fosun Pharma and two scientists in 2010 to develop and deliver biosimilars -- relatively affordable versions of brand-name drugs innovated elsewhere. Evolving from a research-based biotech company to more of a biopharmaceutical company that creates its own final products, Henlius went public at the Hong Kong Stock Exchange in 2019.
Fifteen years after its birth, Henlius has 'grown up,' CEO Jason Zhu recently told Forbes China. Helped particularly by an expanding portfolio of cancer drugs, Henlius's revenue climbed 6% from 2023 last year to reach a record 5.7 billion yuan. Net income in 2024 climbed by half to 820.5 million yuan – the company's second straight year of profits. Last year's total revenue was more than 60 times Henlius's total of 90 million yuan, or $12.6 million, recorded during the year of its IPO; net profit over that same period reversed from a loss of 874.8 million yuan in 2009. To date, Henlius has had six products approved for marketing in China, along with four globally. For its part, Fosun Group has evolved into a global consumer-oriented group with a strong presence in the biopharmaceutical industry.
Henlius has succeeded by combining short- and long-cycle investments, Zhu said. The Shanghai-based company is trying to balance 'low-risk, high-certainty' risks with 'high-risk, high-reward' innovation such as in antibody-drug conjugates; the latter offer exponential returns from bring high costs and complexity, he said. Henlius's success has been borne out at the stock market. Shares have recouped ground lost during Covid, and more than doubled in the past year to as much as HK$51.5.
Zhu sees more growth ahead, based on a pipeline of cancer and ophthalmologic drugs, as well as expanded international partnerships. The company 'is committed to achieving a balanced revenue structure between domestic and global markets,' Zhu said. That suggests it has a lot of room to grow: international revenue was only 14% of its total in 2024. Henlius's overseas business goal is supported by accelerating product launches in the EU, U.S., Latin America and the Asia-Pacific, expanded licensing agreements; and deepening collaboration with global partners, he said.
Henlius's gains to date are part of a boom in China's home pharmaceutical market. Spending in the world's second-most populous nation is expected to reach $126.6 billion in 2023, growing 7.8% annually, according to figures released in late 2024. Growing business helped more than four dozen mainland China healthcare industry leaders make the 2025 Forbes Billionaires List.
Zhu got into medicine based on an early interest in science, a shortage of physicians in China, and a belief that doctors can 'change the course of a person's life.' He graduated from Shanghai Medical College in July 2001, and went on to work as an internal medicine physician in Huashan Hospital in Shanghai. He later transitioned into the industry, where he held senior roles across clinical and business development, including as global vice-president of IQVIA Holdings Inc., and as the founder and chief executive officer of Shanghai PPC Biopharmaceutical Technology. Zhu first joined Henlius in January 2021 as a senior vice president and chief medical officer; he rose to president 11 months later and has been CEO since July 2023.
Henlius – which takes its name from an early founder and a Greek god – has benefitted from the sale of drugs that can treat mainstream cancers -- breast, lung, and gastrointestinal. Cancer incidence in both China and overseas is expected to rise due to gaining populations, environmental exposure and lifestyle changes, Zhu noted. China and the U.S. along account for about 40% of the world's cancer cases. Though cancer is traditionally treated through chemotherapy, radiology or surgical removal, newer biologic medicine offers a more precise approach, such as targeting the cancer cells through the body's immune system.
The global rise of cancer illustrates the universality of many diseases and why internationalization is a natural course for many pharmaceutical companies able to offer treatments, said Zhu. The marginal cost of expanding a drug to new global markets is relatively low once development is complete, but the commercial upside is exponential, he said. One treatment can be licensed as dozens of branded products globally under different distributors. Zhu believes the company's most promising pipeline drug is HLX43, a novel, cancer-fighting PD-L1 antibody-drug conjugate, Zhu said. 'HLX43 exemplifies Henlius's next-generation innovation strategy—combining immune checkpoint blockade with targeted cytotoxic delivery to enhance anti-tumor efficacy while minimizing off-target effects,' he said.
To boost its international business, Henlius will increase investment in its international commercial teams, transitioning from out-licensing to self-marketing, buoyed by innovation, Zhu said. 'The U.S. has long known for innovation, while companies in China are now better at industrialization,' says Zhu. Henlius's leader wants to 'combine innovation with this knack of industrialization. Innovation can be described as doing something abnormal. Innovation means you want to do things differently and push beyond established forms.'
Investigators and global collaborators gathered at the Henlius reception during the annual meeting ... More of the American Society of Clinical Oncology held in Chicago May 30-June 3 this year. Shanghai Henlius
To be sure, geopolitical tensions this year are hard to ignore. 'While geopolitical tensions may present uncertainties, we believe high-quality, life-saving treatments will continue to find their place globally.'
In Asia, Henlius is expanding its investment and talent; Japan is a strategic market where Henlius opened a wholly owned subsidiary this year. There, Henlius is exploring 'hybrid go-to-market' models and working to advance drug candidates to fight gastric and small cell lung cancer, among other illnesses. 'This move is part of Henlius's broader globalization strategy to expand its international footprint with end-to-end capabilities—from clinical development and regulatory filing to market access and commercialization,' Zhu said.
Emerging markets like the Middle East offer high growth and less competition, Zhu believes. In Latin America, Henlius partners with leading local companies to distribute treatments throughout the region. The company has conducted international clinical development trials in the U.S., EU, Australia, Southeast Asia, and Japan. Its commercial partnerships with over 20 global firms, including Accord, Abbott, Eurofarma, Organon, and Sandoz. Sandoz just this year agreed to pay Henlius $31 million as part of a licensing agreement that involved a biosimilar HLX13.
Shareholders investors optimistic about Zhu's leadership and Henlius's growth prospects rejected a privatization offer by Fosun Pharmaceutical earlier this year for HK$24.60 share. Does the subsequent big increase in its share price augur a new round of capital-raising? 'Henlius maintains a disciplined approach to capital strategy. While the company is currently well-capitalized, it remains open to strategic financing opportunities that could accelerate global R&D programs or support entry into new markets. Any fundraising plans would align with shareholder value creation,' Zhu said.
A physician who worked closely for years with ill patients, Zhu reflected in a personal way how business decision-making can similarly be difficult. 'We cannot do everything. Sometimes we have to say no to our heart. Every year I have to say no over 50 times. During the development process, if we're not 100% confident about identifying the right differentiators to address patient needs then we regretfully have to say, 'Sorry, I cannot move you along to the next stage.''
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Keeping Cool and Connected: Attendee Wellbeing Strategies for Summer Outdoor Events
Keeping Cool and Connected: Attendee Wellbeing Strategies for Summer Outdoor Events

Skift

timean hour ago

  • Skift

Keeping Cool and Connected: Attendee Wellbeing Strategies for Summer Outdoor Events

Ensure attendee wellbeing at summer outdoor events with tips on heat, hydration, accessibility, and real-time engagement. It's 2:45 PM. The outdoor breakout session under a tent is running long. Someone near the front is fanning themselves with a printed agenda. Your phone battery is at 11%. And the networking energy you planned for this moment? Gone. Sound familiar? When you're organizing a summer event with outdoor components, things can go sideways quickly if you don't think ahead about attendee well-being. From heat and fatigue to Wi-Fi issues and sensory overload, the risks are real. And today's attendees are clear about what they expect: comfort, care, and options that support how they show up. Wellness at outdoor events is no longer just a hospitality "nice-to-have". It's a core part of creating a high-quality experience. Why Attendee Wellbeing Must Be a Priority for Outdoor Events Image from Skift India Forum A good agenda won't matter much if people are dehydrated or overheated. When attendees aren't physically comfortable, it's hard for them to stay mentally present. Add in outdoor distractions, long walking distances, and limited shade, and even the best programming can lose its impact. Wellness matters because it affects everything else. Attention spans. Energy levels. Willingness to participate. If people feel drained, they check out early or disengage entirely. As the organizer, your role is not just to plan the schedule. It's to create the conditions for attendees to actually benefit from it. What Can Go Wrong Outside (if You Don't Plan Ahead) These are the most common outdoor challenges you'll need to plan around: Heat and sun exposure (see how soaring heat impacts events) Risk of dehydration Long walks with limited seating or shade Sensory overload from crowd noise, traffic, or music Accessibility issues on grass, gravel, or uneven ground Spotty Wi-Fi and charging access Lack of quiet or private spaces Wind, rain, and storms Each of these impacts attendee focus and satisfaction. According to the 2025 Cvent planner sourcing report, 26% of planners say a poor attendee experience would deter them from returning to a venue in the future, highlighting the direct business implications of neglecting wellbeing. The good news? Each one is manageable with thoughtful planning. Tactical Wellness Strategies You Can Implement Today Photo Credits: Panasonic Let's get specific. These are field-tested ways to build wellness into your summer outdoor event, even on a tight timeline or budget. 1. Make Physical Comfort Easy Provide plenty of shaded areas using tents, umbrellas, or existing tree cover Place water refill stations near every major gathering zone Offer cooling towels or portable fans at check-in and wellness stations Set up misting areas near high-traffic spaces if your venue allows Stock sunscreen in shared spaces and bathrooms Example: Panasonic's Dry Mist System, showcased at CES 2024, used a micro-mist curtain to reduce heat stress in open-air environments. If you can only do one thing: Put shade and water within easy reach of every session area and lounge zone. 2. Reduce Mental and Physical Fatigue Break up long sessions with movement-friendly transitions Avoid full-sun exposure for keynotes or breakouts if possible Create rest zones with seating that feels close to the action, not off to the side Build in buffer time between sessions to allow people to recharge Example: Some planners integrate brief wellness activations like 10–15 minute brain-boosting exercises or somatic breathwork sessions between meetings to help attendees recharge both mentally and physically. Dami Kim, director of Body and Brain Corporate Wellness, recommends brain-boosting exercises to improve focus, while Sepideh Eivazi, of Dawn of the Earth and the Global Wellness Institute, offers breathwork to reduce stress and increase energy. What this looks like: Bean bags under trees, a mobile lounge cart with fans and snacks, or hammocks in a quieter corner. 3. Serve Light, Energy-Supporting Food and Drinks Choose foods that feel fresh and easy to digest in the heat: fruit, wraps, salads, popsicles Clearly label all dietary options and allergen information Keep snacks and drinks stocked beyond just meal windows Tip: Offer branded electrolyte packets or chilled fruit-infused water as a low-cost, high-impact touch. For inspiration, check out 25 Health Cautious Catering Ideas for Your Meetings and Events 4. Keep People Engaged and Equipped Set up mobile charging stations throughout the space Provide printed maps and schedules as a backup to apps Use clear signage and wayfinding to minimize walking confusion Train staff to help with tech, logistics, and comfort questions on the fly Add a Wellness Response Team: Assign a few staff or volunteers to check on guests, refill hydration stations, and spot people who may need a break. Give them badges or shirts so they're easy to spot. What Not to Do Some common mistakes are easy to avoid once you know what to watch for: Putting hydration stations far from breakout areas Scheduling anything in the midday sun Relying only on digital tools in a space with weak connectivity Ignoring terrain challenges for guests with mobility needs Forgetting quiet or private spaces for nursing, prayer, or sensory recovery Waiting until someone complains before adjusting your setup Relying on long-term weather forecasts Not having a backup plan For more on weather-proofing your event, see Don't Let Climate Change Blow Your Event Away. Monitor Attendee Wellbeing You don't need to guess how attendees are doing. Build in systems to gather quick feedback and adjust fast. Monitor key zones: Are people lingering or leaving? Are the shaded seats full? Empower staff to fix issues on the spot, whether it's restocking water or moving a session into shade Ask volunteers to report what they hear and see Try this: Set up a 'What Would Help You Right Now?' board with sticky notes or a live comment screen. Update your response plan every few hours based on the input. Wellness Drives Engagement and Outcomes When people feel good, they stay longer. They network more. They absorb what you've worked hard to deliver. Prioritizing wellness during an outdoor event isn't just thoughtful but strategic. You don't need a spa tent or a massive budget to get this right. You need intention and visibility. And you need a team that's empowered to care for people in real time. Because when attendees feel taken care of, they take more away from the experience.

China's Growth Momentum Offers Xi Rare Window to Fight Deflation
China's Growth Momentum Offers Xi Rare Window to Fight Deflation

Bloomberg

timean hour ago

  • Bloomberg

China's Growth Momentum Offers Xi Rare Window to Fight Deflation

China's humming factories threw a lifeline to an economy struggling with weak demand in the second quarter. That's also given policymakers space to fight deflation — if they choose to do more than just hitting their growth target. Gross domestic product beat expectations to grow 5.2% between April and June, bringing the official 5% expansion goal for the year within reach. But while strong exports made up for sluggish consumption at home, they also masked a worsening decline in prices that threatens to drag the world's second-largest economy into a prolonged slowdown.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store